Clinical trials for Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant
3 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ENROLLING BY INVITATIONNCT07050160Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic VariantLexeo Therapeutics · PI: Lexeo Clinical Trials
- RECRUITINGPhase 2NCT06174220Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic CardiomyopathyHamilton Health Sciences Corporation · PI: Jason D Roberts, MD MAS
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06109181Gene Therapy for ACM Due to a PKP2 Pathogenic VariantLexeo Therapeutics · PI: LEXEO Clinical Trials